Microrelin

3.75mg

Triptorelin Acetate S.R.

karma-Microrelin3.75
MICRO 3.75 homapharmed
path-6-dimention

Abbreviated prescribing information:

MICRORELIN ® 3.75 mg contains the active ingredient of triptorelin acetate 3.75 mg. The sustained release formulation of MICRORELIN® allows continuous release of the drug over 30 days so that 3.75 mg of triptorelin peptide correspond to a maximum dose of 0.100 mg/day plus a 25% excess.

Therapeutic indications:

Advanced hormone dependent prostatic cancer. Other situations where lowering of sex steroid serum levels to castrate level is desired, such as endometriosis, uterine myoma. MICRORELIN ® is used in treatment of confirmed central precocious puberty (girls under 9 years, boys under 10 years).

about women micro 3.75

WOMEN

A Reliable choice for ENDOMETRIOSIS & UTERIN FIBROIDS

The use of MICRORELIN ® has to be carefully evaluated in patients with premonitory signs of modularly compression and the medical surveillance has to be closer in the first weeks of treatment, particular in patients with spinal metastases. In order to prevent accentuation of the clinical symptoms, supplementary administration of an appropriate antiandrogen agent should be considered in the initial phase of the treatment.

about men micro 3.75

MEN

A Reliable choice for Prostate Cancer

The use of MICRORELIN ® has to be carefully evaluated in patients with premonitory signs of modularly compression and the medical surveillance has to be closer in the first weeks of treatment, particular in patients with spinal metastases. In order to prevent accentuation of the clinical symptoms, supplementary administration of an appropriate antiandrogen agent should be considered in the initial phase of the treatment.

child micro3.75

CHILD

A Reliable choice for central precocious puberty

The chronological age at the beginning of therapy should be under 9 years in girls and under 10 years in boys.

micro3.75 homapharmed

Side effects:

The most commonly observed adverse events during triptorelin treatment are due to the expected physiological effects related to decreased testosterone levels. These effects included hot flushes, erectile dysfunction, and decreased libido. If these conditions are aggravated, it may lead to neurological problems such as weakness and/or paresthesia of the lower limbs or worsening of urinary symptoms. In rare cases allergic reaction or more rarely nausea, vomiting, weight gain, hypertension, mood disorders, visual disturbances, fever or pain at the injection site may occur.

Special precautions for storage:

MICRORELIN ® should be stored between 15-25°C. Keep out of the reach and sight of children.